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Previously we reported that astroglial cells cultured from mouse brain synthesize and secrete nerve growth factor (NGF) and that, in quiescent 
cells, catecholamines markedly increase the NGF content in the conditioned medium (CM). We wished to further assess the structural properties 
required for exhibition of such effect of compounds containing a ring structure analogous to that of catechol on astroglial NGF synthesis. During 
our study, we found that hydroquinone, which was confirmed not to stimulate .NGF synthesis in mouse fibroblast cells in another of our investiga- 
tions, is a potent stimulator of NGF synthesis in astroglial cells and that 1,4benzoquinone, an oxidized form of hydroquinone, is a more effective 
stimulator than hydroquinone itself. In addition, the results of experiments with 1,2benzoquinone derivatives indicated that the presence of a long 
aliphatic side chain in the molecule liminates the stimulatory effect of 1,4-benzoquinone on NGF synthesis in astroglial cells. 
Nerve growth factor; 1,4-Benzoquinone; Coenzyme QO; Vitamin K,; (Astroglial cell) 
1. INTRODUCTION 
NGF is a protein that is required for the development 
and maintenance of sympathetic and some sensory 
neurons [ 1,2]. NGF is thought to be synthesized in in- 
nervated end organs and retrogradely transported to 
the neuronal cell body [3,4]. In fact, mRNA of NGF 
has been detected in the various end organs which are 
sympathetically innervated [5,6]. 
on NGF has shown that continuous intracerebral infu- 
sion of NGF could partly reverse the cholinergic cell 
body atrophy and improve retention of a spatial 
memory task in behaviorally impaired aged rats [15]. 
This effect of exogenously applied NGF suggests that 
stimulation of synthesis/secretion of endogenous NGF 
would be a more efficient and rather more practical 
means for therapy and/or prevention of neuronal 
disorders in the brain than exogenously applied NGF. 
A few years ago, we developed a highly sensitive EIA 
for mouse ,& NGF, which is the active subunit of the 
submaxillary gland NGF known as 7s NGF [7]. By us- 
ing this EIA system, we demonstrated that fibroblast 
cells cultured from various organs of mice synthesize 
and secrete a molecule identical to submaxillary gland 
p NGF [8,9]. In those studies, we found that 
catecholamines induce an increase in the NGF content 
of CM and that this effect is due to the presence of a 
catechol ring in the molecule [9-l 11. 
As for cells cultured from mouse brain, we showed 
that astroglial cells synthesize and secrete NGF, sug- 
gesting that glial cells are responsible for regulation of 
NGF in the brain [16]. Further, we found that addition 
of catecholamines to quiescent astroglial cells causes 
acceleration of their NGF synthesis as in the case of 
mouse fibroblast cells [I 1,171. This indicated the 
possibility to develop new types of drugs that regulate 
the NGF content in the brain. 
NGF has been found in the brain as well, and it has 
been reported that NGF functions as a neurotrophic 
molecule for the cholinergic neurons in the basal 
forebrain nuclei thought to be responsible for learning 
and memory [12-141. A recent pharmacological study 
To further investigate the structural properties of the 
compounds exhibiting a stimulatory effect on NGF 
synthesis in astroglial cells, we examined the effect of 
compounds that contain a ring structure analogous to 
that of catechol in their molecules. 
2. MATERIALS AND METHODS 
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2.1. Materials 
Abbreviations: NGF, nerve growth factor; EIA, enzyme im- 
munoassay; BSA, bovine serum albumin; FCS, fetal calf serum; 
DMEM, Dulbecco’s modified Eagle’s medium; CM, conditioned 
medium 
Mouse submaxillary gland p NGF and anti-b NGF antiserum were 
prepared as described previously [7]. DMEM was obtained from 
Nissui; FCS, from Bockneck; cell culture vessels, from Falcon; BSA, 
from Armour; idebenone and hydroquinone-idebenone, from 
Takeda Chemical Industries, Ltd. All other chemicals were obtained 
from either Nacalai Tesque Inc. or Woko Chemical Industries. 
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2.2. Cell etilfure 
Astroglial cells were cultured from the whole brain of I-day-old 
ICR mice and m~nt~ned in DMEM containing 10% FCS as describ- 
ed before 1161. The preparation of the quiescent astroglial cells was 
performed according to the procedures previously reported [17]. 
Namely, astroglial cells were inoculated into 24-well plates (well sur- 
face, 2.1. cm*) and cultured in FCS-containing DMEM until con- 
fluence was reached (about 1.5 x IO6 cells/cm*). Then they were 
cultured for an additional 2 weeks in FCS-free DMEM containing 
0.5% WA, with a medium change every 3 days. Most of the cells 
were arrested in the quiescent phase. The cells were cultured for 24 h 
in 0.5 ml of DMEM containing 0.5% BSA with or without the 
desired drug, and then the NGF content in the CM of each culture 
was determined. Since NGF synthesized by astroglial cells is secreted 
rapidly into the CM, the measurement of NGF content in CM reflects 
the amount of NGF synthesized 116,171. 
2.3. Two-site EZA 
The contents of NGF in the CM of astroglial cells treated with test 
samples were determined by our two-site EIA for mouse submaxillary 
gland p NGF [7]. As hy~oquinone and other drugs used in this 
study, as well as the uncondition~ medium, did not affect the EIA 
system, the CM was directly applied to the wells for the EIA. 
Fig.2. Effect of hydroquinone and 1,4-benzoquinone on the NGF 
content in medium conditions by mouse astroglial cells. Same as 
legend to fig. 1 except hydroquinone (0) and 1,4-benzoquinone (0) 
were tested. 
3. RESULTS 
The stjmulatory effect of catecholamines on NGF 
synthesis in mouse fibroblast cells was earlier confirm- 
ed to be due to the presence of a catechol ring in the 
molecules [lo]. This was based on the result that 
catechol itself exhibited a weak effect, while its posi- 
tional isomers, resorcinol and hydroquinone, were inef- 
fective. Since the requirement of a catechol ring for the 
exhibition of the stimulatory effect in astroglial cells 
had not been assessed, we examined the effect of those 
3 isomers. As shown in fig.1, catechol, possessing its 
two phenolic hydroxyl groups in the outgo-relationship 
was effective for stimulation of astroglial NGF syn- 
thesis in agreement with our previous investigation con- 
cerning NGF synthesis in fibroblast cells [lo]. 
Resorcinol, with the groups in the meta positions, was 
ineffective as a stimulator for astroglial cells as well as 
for fibroblast cells. Hydroquinone, with the two groups 
in the para-configuration and confirmed not to 
stimulate NGF synthesis in fibroblast cells, surprisingly 
exhibited a stimulatory effect on NGF synthesis in the 
astroglial cells. Its dose-response curve was bell- 
shaped. The NGF content in CM of astroglial cells 
treated with 0.1 mM hydroquinone corresponded to 15 
times that of control cultures, while that of cells treated 
with 0.15 mM was the same as the control value. This 
phenomenon was likely caused by the cytotoxicity of 
hydroquinone, because some dead cells appeared at the 
concentration of 0.1 mM, and almost all cells died at 
concentrations over 0.15 mM, 
These results present the possibility that drugs other 
than catechol derivatives may be useful stimulators of 
NGF synthesis. As the cytotoxicity of derivatives of 
catechol and its positional isomers can be diminished 
by modification of the aliphatic side chain or by 
esterification of the phenolic hydroxyl groups [18], we 
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Fig.1. Effects of catechol and its isomers on the NGF content in medium conditioned by mouse astroglial cells. After a 24-hr incubation with 
various concentrations of catechol (o), resorcinol (o), or hydroquinone (A.), medium was collected. The NGF content in the medium was 
determined EIA and expressed as fold increase over that in the absence of a given drug. Each point is the mean + SE of four determinations. 
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Fig.3. Effects of hydr~uinone idebenone and idebenone on the NGF 
content in medium conditioned by mouse astroghal cells. Same as 
legend to fig.1 except hydroquinone idebenone (0) and idebenone 
(0) were tested and three determinations were made. 
examined the effect on NGF synthesis of various 
derivatives of hydroquinone. Fig.2 shows the effect of 
1,4-benzoquinone, an oxidized form of hydroquinone. 
As the phenohc hydroxyl groups of the latter are easily 
oxidized, the former is more stable. The NGF content 
in CM from cells treated with 0. X5 mM l,Cbenzo- 
quinone was 20 times greater than that of the control. 
Although the cytotoxicity of 1,Cbenzoquinone was 
also evident, this form was indicated to be more useful 
than hydroquinone as a stimulator of NGF synthesis. 
Fig.3 shows that idebenone (6-(lO-hydroxydecyl)- 
2,3-dimethoxy-5-methyl-l ,Qbenzoquinone), a 1,4-ben- 
zoquinone derivative, had a similar range of effective 
concentrations as 1,4-benzoquinone had. The increase 
in NGF content brought about by idebenone at its 
optimal concentration (0.175 mM) was 7-fold of the 
control. Fig.3 also shows that idebenone was more ef- 
fective than its hydroquinone form, 6-( IO-hydroxyde- 
cyl)-2,3-dimethoxy-Smethylhydroquinone, 
Fig.4. Effects of 2,3-dimethoxy-S-methyl-1,4-benzoquinone derivatives on the NGF content in medium conditioned by mouse astroglial cells. 
Same as legend to fig.1 except coenzyme QO (o), coenzyme Qz (O), idebenone (A), and ubiquinone 50 or coenzyme Qro (A) were tested and three 
determinations were made. 
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Fig.5. Effects of vitamins K1 and Ks on the NGF content in medium conditioned by mouse astroglial cells. Same as legend to fig.1 except vitamin 
Kr (0) and Ks (0) and three determinations were made. 
Vitamin K, O----O 
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Fig.4 reveals that the effects of 2,3-dimethoxy-5- 
methyl-l ,Cbenzoquinone (coenzyme Qo) and coen- 
zyme 42 on NGF synthesis were almost the same as the 
effect of idebenone. On the other hand, ubiquinone 50 
(coenzyme Qie), which has a much longer aliphatic 
chain, was ineffective for stimulation of NGF syn- 
thesis. Fig.5 demonstrates that vitamin K3 (Zmethyl- 
1,4_naphthoquinone) was effective for stimulation on 
NGF synthesis, while vitamin Ki, possessing an 
aliphatic side chain consisting of 20 carbons, was inef- 
fective. These results indicate that the presence of a 
long aliphatic side chain hinders the stimulatory effect 
of 1,Cbenzoquinone and that the presence of less than 
10 carbons is likely to be permissive for the effect. The 
decreases observed in their effects at high concentra- 
tions was caused by their cytotoxicity. 
4. DISCUSSION 
The present results indicate that a catechol ring is not 
always necessary for exhibition of a stimulatory effect 
on NGF synthesis in mouse astroglial cells. We found 
that hydroquinone and its oxidized form (l,Cbenzo- 
quinone) also have a stimulatory effect on NGF syn- 
thesis. As they were cytotoxic at their high concentra- 
tion, we focused our attention on examining the effect 
of their derivatives, that is, idebenone, coenzyme Q, 
and vitamin K. We have not yet succeeded to find any 
drugs without cytotoxicity. In the future we will syn- 
thesize various drugs having the 1 ,Cbenzoquinone ring 
and examine their effect on NGF synthesis and cyto- 
toxicity. 
Although we have not yet examined how l,Cbenzo- 
quinone derivatives affect the NGF content, we predict 
that they stimulate the de novo synthesis of NGF pro- 
tein, as catechol is known to do [ 11,171. In preliminary 
experiments, we observed that these drugs did not af- 
fect [3H]thymidine incorporation, suggesting their in- 
dependence of cell growth. 1 ,CBenzoquinone might 
specifically affect the NGF mRNA level. 
Several recent findings have indicated that intraven- 
tricular or intracerebral injection of NGF prevents 
neuronal death in rat brain lesioned mechanically or 
chemically [ 13-151, which opens up the interesting 
possibility that NGF may be useful as a therapeutic 
agent for diseases of the central nervous system such as 
Alzheimer’s disease. As NGF itself does not cross the 
blood-brain barrier, and human NGF is not available, 
it would appear worthwhile to attempt o develop syn- 
thetic compounds having the ability to stimulate the 
synthesis of endogenous NGF. Although benzoquinone 
may be useful, it seems to be easily metabolized and 
does not cross the blood-brain barrier. On the other 
hand, benzoquinone derivatives with short aliphatic 
side chains in the benzene ring are able to pass the 
blood-brain barrier, as idebenone has proven to be a 
drug that improves blood flow in the brain and has 
been already put to use. We thus plan to develop com- 
pounds employing the 1,Cbenzoquinone ring as the 
basal skeletal structure as potential candidates of drugs 
that regulate the NGF content in the brain. Derivatives 
of coenzyme Q or vitamin K might prove to be useful 
drugs. 
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